Clinical Trials Feature Articles

41. A Dynamic Approach To Models In Phase I
    3/4/2008
    The primary focus in Phase I clinical trials has traditionally been the assessment of safety, tolerability, and pharmacokinetics. However, there has been increasing interest over the last decade in the application of biomarkers and surrogate endpoints in healthy volunteer studies to provide information on putative efficacy, dose response, and time effects of investigational drugs. Submitted by ICON
42. FDA Guidance Focuses On Cancer Trial Endpoints
    3/4/2008
    This article will explore the impact the FDA's guidance, "Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics," is having on the clinical research industry, and the increasingly important role that imaging has in the assessment of cancer tumors. Submitted by ICON
43. Article: FDA Guidance Focuses On Cancer Trial Endpoints
    3/4/2008
    Article: FDA Guidance Focuses On Cancer Trial Endpoints
44. Article: A Dynamic Approach To Models In Phase I
    3/4/2008

    Article: A Dynamic Approach To Models In Phase I

45. White Paper: Improving Water System Performance: A Continuous TOC Measurement Technology To Enhance Real-Time Process Control
    2/20/2008
    White Paper: Improving Water System Performance: A Continuous TOC Measurement Technology To Enhance Real-Time Process Control